Venky's (India) Q1 FY27 Results (NSE: VENKEYS)

· Analysis by Alpha Inflection

Signal: Margin expansion

The read

The key inflection is a sharp operating recovery: EBITDA rose +134.4% YoY and margin expanded 330bps to 7.4% despite raw-material cost rising to 70.0% of revenue from 63.9%; management attributes the revenue and segment improvement to higher volumes, realizations, product mix and cost optimisation, but the 13.3% asset-base increase against 1.9% depreciation growth is an earnings-quality monitor.

Venky's (India) Q1 FY27 key financials
MetricValueYoYQoQ
Revenue₹1,118.38 Cr29.2%+1.6%
EBIT₹73.21 Cr180.9%
Net profit₹49.99 Cr215.8%
EPS₹35.49215.7%
EBIT margin7.4%

P&L walk

Revenue increased to ₹1,11,838 lakh, +29.2% YoY and +1.6% QoQ, but material costs rose faster at +41.6% YoY; EBITDA nevertheless grew +134.4% and margin expanded to 7.4% as employee costs, depreciation and finance costs grew far slower than revenue, while PAT rose +215.8% on clean operating improvement.

Segments

Oilseed was the main growth engine, with revenue up 66.3% YoY to ₹52,797 lakh and result up 208.3% to ₹3,096 lakh; Animal Health Products delivered the highest segment margin at ₹3,031 lakh of result on ₹11,357 lakh revenue, while Poultry remained the largest revenue segment at ₹51,689 lakh but contributed only ₹1,625 lakh of result amid higher feed prices.

Key positives

Key concerns

View original filing

Research and educational content only. Not investment advice.